Content area
Full Text
Headnote
HEALTHCARE: New Jersey buyer eyes capacity on generics
Irvine-based drug maker Anchen Pharmaceutical Inc. has struck a deal to be acquired by Par Pharmaceutical Companies Inc. for $410 million.
Woodcliff Lake, N.J.-based Par has annual sales of just more than $1 billion. It said it was buying Anchen to expand its generic drug offerings.
Par and other generic makers are looking for deals as a number of major product patents held by other companies approach expirations.
Getting Anchen "will expand our portfolio of high-value market products, including sustainable products with longer...